IPA to Present at The Microcap Conference 2025
-
Pakistan says Indian missiles strike air bases as conflict spirals
-
Spieth seeks career Slam as rivals ponder Rory Slam chances
-
Major difference for McIlroy at PGA after winning Masters
-
Top-ranked Korda shares LPGA Americas lead in repeat bid
-
US and China prepare for trade talks as Trump floats tariff cut
-
US projected to hit debt limit in August: Treasury chief
-
'You're gonna be the Pope,' Leo XIV's brother recalls telling him
-
Guardiola says Man City season has been toughest in management
-
'It's terrific': Chicago hails hometown hero Pope Leo XIV
-
Europe leaders head to Kyiv on unprecedented visit
-
Pakistan warns won't de-escalate as conflict with India spirals
-
Stocks mixed as global markets eye US-China tariff talks
-
Serbia's Vucic seeks low-price gas in Putin meeting
-
German Holocaust survivor and witness-bearer Margot Friedlaender dies at 103
-
Timberwolves launch probe after fan's 'racially charged' abuse
-
Giro over for Landa after high-speed opening stage crash
-
US approves first at-home cervical cancer screening device
-
FIFA Women's World Cup expanded to 48 teams from 2031
-
Mitchell leads, Lowry charges and Rory five back at rainy Truist
-
Gauff holds nerve to join Sabalenka in Italian Open third round
-
Israel not involved in Gaza food distribution under US aid plan: envoy
-
Margot Friedlaender, Germany's voice of Holocaust remembrance
-
Fallen giant Hamburg close in on top-flight redemption
-
Dozens of minors killed in Mexico cartel infighting
-
Trump fires librarian of US Congress
-
Spurs will show no fear against Man Utd in Europa League final: Van de Ven
-
Renowned Holocaust survivor Margot Friedlaender dies at 103
-
Woods, 16-year-old Charlie, misses out in US Open qualifier
-
Pakistan says India has put neighbours 'closer to major conflict'
-
On patrol for jihadists with Mauritania's camel cavalry
-
France, Poland sign treaty with mutual defence pledge
-
NATO chief seeks defence spending at 5% of GDP by 2032: Dutch PM
-
La Rochelle head coach O'Gara suspended for five weeks
-
Measles roars back in the US, topping 1,000 cases
-
Fulham boss Silva refuses to rule out Saudi switch
-
From Chicago to Chiclayo: Peruvian town hails adoptive son and pope
-
Ivorian women fight FGM with reconstructive surgery
-
Pedersen wins opening stage of Giro d'Italia in Albania
-
Stocks mixed despite hopes for US-China tariff talks
-
US, Swiss agree to speed up tariff talks
-
Trump floats cutting China tariffs to 80% ahead of trade talks
-
Pedersen wins opening stage of Giro d'Italia
-
Marc Marquez sets Le Mans lap record in French MotoGP practice
-
Jungle music: Chimp drumming reveals building blocks of human rhythm
-
Guardiola tells Man City stars to question their hunger after troubled season
-
Putin, Xi, Steven Seagal and missiles: Russia's Red Square parade
-
Trump suggests lower 80% China tariff ahead of Geneva trade talks
-
Arteta wants Arsenal to use Liverpool guard of honour as title fuel
-
Stocks lifted by hopes for US-China talks
-
Putin hails troops in Ukraine as allies attend WWII parade
NYSE - LSE
IPA to Present at The Microcap Conference 2025
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, today announced is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, in Atlantic City, NJ.
IPA's management team will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company's recent developments, growth strategy, and investment opportunities.
About The Microcap Conference 2025
The Microcap Conference is the largest independent microcap event in the U.S., bringing together top-tier investors and executives from microcap companies. The event offers a platform for companies to showcase their value propositions through presentations, one-on-one meetings, and networking opportunities.
The 2025 event will feature:
Keynote Speakers: Renowned industry figures, including Jon Ledecky, Co-Owner of the New York Islanders, who will engage in a fireside chat with CNBC's Bob Pisani; plus Tom Gardner, CEO of Motley Fool, who will share insights on investing, market trends, and entrepreneurial success.
Expert Panels and Presentations: Financial commentators Ron Insana (CNBC) and Charlie Gasparino (FOX Business) will cover critical topics for the US equity markets, from capital formation to regulatory updates and market trends.
Entertainment Headliner: A special performance by Tom Papa, celebrated comedian and host of Netflix specials, ensuring a memorable evening for attendees.
Hosted by DealFlow Events, The Microcap Conference is renowned for its blend of high-quality content, engaging networking, and exceptional entertainment. For more information, visit https://themicrocapconference.com.
About ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and is known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe including entities such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the "IPA Family").
Investor Relations Contact
SOURCE: ImmunoPrecise Antibodies Ltd.
P.Mathewson--AMWN
